Ubs Asset Management Americas Inc Adma Biologics, Inc. Transaction History
Ubs Asset Management Americas Inc
- $277 Billion
- Q1 2024
A detailed history of Ubs Asset Management Americas Inc transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 219,287 shares of ADMA stock, worth $2.46 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
219,287
Previous 187,197
17.14%
Holding current value
$2.46 Million
Previous $846,000
71.04%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding ADMA
# of Institutions
224Shares Held
174MCall Options Held
85.5KPut Options Held
12.8K-
Black Rock Inc. New York, NY18.2MShares$204 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.7MShares$142 Million0.0% of portfolio
-
State Street Corp Boston, MA10.6MShares$118 Million0.0% of portfolio
-
Nuveen Asset Management, LLC Chicago, IL10.5MShares$117 Million0.02% of portfolio
-
Invesco Ltd. Atlanta, GA7.8MShares$87.5 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $2.2B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...